Forbes

Should Patients Be Able To Receive "PFO Occluders" Outside Of Research Trials?

Ten years ago, my tennis partner suffered a stroke. He was a sixty-year-old at the time, working to move up into the top ten players in his age group. In the country! You could not have found a ...
Business Wire

SeptRx® completes enrollment for its “InterSEPT” CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx® Intrapocket PFO Occluder (IPO)

FREMONT, Calif.--(BUSINESS WIRE)--SeptRx®, an emerging medical device company that has developed the SeptRx® Intrapocket PFO Occluder (IPO) — a platform for the percutaneous transcatheter closure of a ...
Healio

Cryptogenic stroke recurrence less likely with PFO closure than medical management

Please provide your email address to receive an email when new articles are posted on . Patent foramen ovale closure appears to be superior to medical management in preventing the recurrence of ...
TCTMD

FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

FLAGSTAFF, Ariz. Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc.
Nature

Can patent foramen ovale closure using the Cardia PFO occluder reduce the occurrence of thromboembolic events?

Data indicate that there could be a link between cryptogenic thromboembolic events and patent foramen ovale (PFO). Although controversial, increasing numbers of patients are undergoing transcatheter ...
TCTMD

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Ending a decades-long wait, the US Food and Drug Administration (FDA) today approved the Amplatzer PFO Occluder device (St. Jude Medical) for recurrent stroke prevention in patients with a patent ...
Forbes

TCT: Two PFO Closure Trials Miss Primary Endpoints

“Percutaneous PFO closure with the investigational Amplatzer PFO Occluder device for secondary prevention of thromboembolism showed no significant reduction in ischemic and bleeding events compared ...
MD&M East

What Does Neurology Group's Recommendation on PFO Closure Mean for St. Jude?

The American Academy of Neurology has recommended against percutaneous closure of a congenital heart defect in patients who have had a stroke just as St. Jude Medical anticipates a device to treat the ...
Healio

RESPECT final analysis: PFO closure reduces risk for recurrent stroke

WASHINGTON — Final results of the RESPECT trial showed that percutaneous patent foramen ovale closure reduced the risk for recurrent stroke compared with guideline-directed medical therapy alone over ...
Business Insider

Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.

SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire/ -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the ...
Medscape

After RESPECT and PC Trial: What Role for PFO Closure?

MIAMI – The Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) and PC Trial were both presented last week at TCT 2012 after ...